Immunocytochemical and molecular data guide peptide identification by mass spectrometry: orcokinin and orcomyotropin-related peptides in the stomatogastric nervous system of several crustacean species.
In order to identify new orcokinin and orcomyotropin-related peptides in crustaceans, molecular and immunocytochemical data were combined with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). In the crayfish Procambarus clarkii, four orcokinins and an orcomyotropin-related peptide are present on the precursor. Because these peptides are highly conserved, we assumed that other species have an identical number of peptides. To identify the peptides, immunocytochemistry was used to localize the regions of the stomatogastric nervous system in which orcokinins are predominantly present. One of the regions predominantly containing orcokinins was a previously undescribed olive-shaped neuropil region within the commissural ganglia of the lobsters Homarus americanus and Homarus gammarus. MALDI-TOF MS on these regions identified peptide masses that always occur together with the known orcokinins. Seven peptide ions occurred together in the peptide massspectra of the lobsters. Mass spectrometric fragmentation by MALDI-MS post-source decay (PSD) and electrospray ionization quadrupole time-of-flight mass spectrometry (ESI Q-TOF MS) collision-induced dissociation (CID) were used in the identification of six of these masses, either as orcokinins or as orcomyotropin-related peptides and revealed three hitherto unknown peptide variants, two of which are [His13]-orcokinin ([M+H]+ = 1540.8 Da) and an orcomyotropin-related peptide FDAFTTGFGHN ([M+H]+ = 1213.5 Da). The mass of the third previously unknown orcokinin variant corresponded to that of an identified orcokinin, but PSD fragmentation did not support the suggested amino acid sequence. CID analysis allowed partial de novo sequencing of this peptide. In the crab Cancer pagurus, five orcokinins and an orcomyotropin-related peptide were unambigously identified, including the previously unknown peptide variant [Ser9-Val13]-orcokinin ([M+H]+ = 1532.8 Da).
Skiebe
P
P
Freie Universität Berlin, Department of Biology, Chemistry, Pharmacy, Institute of Biology, Königin-Luise-Str. 28/30, 14195 Berlin, Germany. skiebe@zedat.fu-berlin.de
Dreger
M
M
Börner
J
J
Meseke
M
M
Weckwerth
W
W
D000595:Amino Acid Sequence; D000818:Animals; D033381:Anomura / Q000033:anatomy & histology / Q000737:chemistry*; D033364:Decapoda / Q000033:anatomy & histology / Q000737:chemistry; D045888:Ganglion Cysts / Q000737:chemistry; D007150:Immunohistochemistry; D008340:Mandibular Nerve / Q000737:chemistry; D018613:Microscopy, Confocal; D008970:Molecular Weight; D008121:Nephropidae / Q000033:anatomy & histology / Q000737:chemistry*; D009479:Neuropeptides / Q000032:analysis*; D019581:Neuropil / Q000737:chemistry; D017933:Peripheral Nervous System / Q000033:anatomy & histology / Q000737:chemistry*; D020033:Protein Isoforms / Q000032:analysis / Q000502:physiology; D021241:Spectrometry, Mass, Electrospray Ionization; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D013270:Stomach / Q000294:innervation
D009479:Neuropeptides; D020033:Protein Isoforms; C417162:phenylalanyl-aspartyl-alanyl-phenylalanyl-threonyl-threonyl-glycyl-phenylalanylamide; C079067:orcokinin